指南与共识头颈部肿瘤放疗

AIRO与GORTEC关于低中危早期口腔鳞状细胞癌术后放疗的共识

AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).
指南 / 共识 · Radiother Oncol · 2022-11-03

AIRO与GORTEC两个国家放射肿瘤学协会组成工作组,针对低中危早期口腔鳞状细胞癌术后放疗指征提出14个临床相关问题,经文献综述后由专家小组采用改良德尔菲法投票,首轮即对14条陈述达成一致;对争议较大的两条陈述进一步提出临床病例讨论,显示决策异质性更明显。

要点

  • 两协会工作组确定14个与低中危早期口腔鳞癌术后放疗指征相关的临床问题并完成文献综述。
  • 专家小组采用改良德尔菲法对14条陈述投票,首轮投票即达成一致。
  • 对两条争议较大且一致性较低的陈述提出临床病例,显示决策异质性更明显。

核心结论

  • 两协会间达到的良好共识水平为临床选择提供相关支持,同时承认一般性指征不能适用于所有临床情况,也不能替代多学科讨论。

研究设计与样本

  • AIRO与GORTEC两个国家放射肿瘤学协会的工作组成员确定14个临床相关问题,进行文献综述,并由专家小组采用改良德尔菲法对形成的陈述进行评级,仅放射肿瘤学家参与讨论和投票。

主要发现

  • 首轮投票即对14条陈述达成一致。
  • 对两条争议较大且一致性较低的陈述提出临床病例,临床病例显示更明显的决策异质性。

关键数值与推荐

  • 原文未报告具体推荐条款、推荐等级或数值标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出一般性指征不能适用于所有临床情况,也不能替代多学科讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Evidence on the efficacy of postoperative radiotherapy (PORT) in low-intermediate risk squamous cell carcinoma of the oral cavity (OSCC) remains inconclusive. Members of a task force from two national radio-oncology Associations (AIRO and GORTEC) defined 14 clinically relevant questions to identify "gray areas" pertinent to the indication for PORT in this clinical setting. Consequently, a literature review was performed on the topic. The resulting statements were then rated by an Expert Panel (EP) using a modified Delphi method. Only radiation oncologists were part of the discussion and voting on the scenarios. There was agreement on the 14 statements at the first round of voting. The task force then decided to propose clinical cases for the two more controversial statements that had received a lower agreement to better capture the Experts' attitudes. The clinical cases highlighted a more significant decisional heterogeneity. However, the good level of consensus reached among the two Associations gives relevant support in informing clinical choices while acknowledging general indications cannot fit all clinical situations and do not replace multidisciplinary discussion.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Merlotti A, Alterio D, Orlandi E, et al. AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC). Radiother Oncol. 2022. PMID: 36336113. doi:10.1016/j.radonc.2022.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。